AI-generated summary
This review describes xenon light therapy, which uses broad-band, non-coherent light across ultraviolet to infrared wavelengths, with 500 to 700 nm suited to superficial tissue and 800 to 1,000 nm to deeper tissue. The authors report that research on its use for tissue repair and pain reduction is limited to open-label studies and case reports. The review draws on available in vitro and in vivo evidence, much of which used single-wavelength laser beams.
- Who or what was studied
- unclear
- Wavelengths
- 500, 700, 800 nm
- Limits stated in the abstract
- The abstract states that research is restricted to open-label studies and case reports, and much of the cited evidence used single-wavelength laser beams rather than xenon light.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 500-700 nm, 000 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Ultraviolet, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.